Injective vs Hyperliquid: A Tale of Two Layer 1 Blockchain Networks

The battle for dominance between Injective and Hyperliquid is at the forefront of the 2026 DeFi infrastructure landscape. These two Layer 1 blockchain networks are built on different foundations, with distinct architecture and design approaches.

Injective, launched in 2018, uses Tendermint-based Proof-of-Stake consensus with sub-second finality and features MultiVM, a system allowing multiple smart-contract languages to target the same shared liquidity layer. In contrast, Hyperliquid is a purpose-built L1 designed exclusively around its perpetuals exchange, with two layers working as one system.

The current state of affairs shows Hyperliquid holding a significant lead in perp DEX volume and institutional access through spot ETFs on NYSE Arca. However, Injective has made notable progress with the launch of native USDC and CCTP support, closing its biggest infrastructure gap. This development removes bridge risk for institutional treasuries and facilitates easier settlement of USDC on Injective.